Livforsakringsbolaget Skandia Omsesidigt Sells 600 Shares of Colgate-Palmolive (NYSE:CL)

Livforsakringsbolaget Skandia Omsesidigt reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 30.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,346 shares of the company’s stock after selling 600 shares during the period. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Colgate-Palmolive were worth $131,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in CL. Hexagon Capital Partners LLC boosted its stake in Colgate-Palmolive by 9.5% during the 2nd quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company’s stock valued at $124,000 after purchasing an additional 110 shares during the last quarter. Legacy Trust boosted its position in shares of Colgate-Palmolive by 1.7% during the first quarter. Legacy Trust now owns 6,925 shares of the company’s stock valued at $624,000 after buying an additional 116 shares during the last quarter. Checchi Capital Advisers LLC increased its holdings in Colgate-Palmolive by 1.5% in the 1st quarter. Checchi Capital Advisers LLC now owns 7,829 shares of the company’s stock worth $705,000 after buying an additional 118 shares in the last quarter. Regal Investment Advisors LLC raised its position in Colgate-Palmolive by 1.6% in the 4th quarter. Regal Investment Advisors LLC now owns 7,574 shares of the company’s stock worth $604,000 after buying an additional 121 shares during the last quarter. Finally, M&G Investment Management Ltd. lifted its stake in Colgate-Palmolive by 0.3% during the 4th quarter. M&G Investment Management Ltd. now owns 49,269 shares of the company’s stock valued at $3,942,000 after acquiring an additional 125 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have issued reports on CL. Bank of America boosted their price target on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Sanford C. Bernstein upped their target price on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a report on Tuesday, July 30th. Evercore ISI increased their price target on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a research report on Thursday, July 18th. Citigroup upped their price objective on Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Finally, Royal Bank of Canada lifted their target price on Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a research report on Monday, April 29th. Eight research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus price target of $101.11.

Colgate-Palmolive Trading Down 1.1 %

Shares of Colgate-Palmolive stock traded down $1.16 on Monday, reaching $100.91. The company had a trading volume of 1,272,638 shares, compared to its average volume of 4,413,266. The firm’s 50-day moving average price is $97.49 and its two-hundred day moving average price is $91.66. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $104.15. The firm has a market cap of $82.79 billion, a price-to-earnings ratio of 32.30, a P/E/G ratio of 3.54 and a beta of 0.39. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.28.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm had revenue of $5.06 billion for the quarter, compared to analysts’ expectations of $5 billion. During the same quarter in the prior year, the firm posted $0.77 earnings per share. The company’s quarterly revenue was up 4.9% on a year-over-year basis. As a group, research analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.98%. The ex-dividend date of this dividend is Friday, July 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Insider Buying and Selling

In other news, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the sale, the executive vice president now owns 10,377 shares in the company, valued at approximately $1,069,868.70. The disclosure for this sale can be found here. 0.34% of the stock is owned by insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.